The $6 Billion Shot at Making New Antibiotics
Antimicrobials cost as much to develop as other drugs, but don’t earn the same returns. Congress could give drugmakers a boost, but time is running out. ..
Antimicrobials cost as much to develop as other drugs, but don’t earn the same returns. Congress could give drugmakers a boost, but time is running out. ..
The legislation adds fuel to a major push for a US battery supply chain. But inconvenient geography is the least of the challenges ahead. ..
Batteries and renewable energy alone can’t decarbonize industries, and recent proposals for a “hydrogen economy” could bridge those gaps. ..
Democratic senators lacked actionable gun data for their negotiations—so they passed mental health reform instead. ..